BioSpace News Archive

OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand.

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today joins the Alagille community in commemorating the second annual International Alagille Syndrome Awareness Day on January 24, 2021 in honor of Dr. Daniel Alagille’s birthday. Alagille syndrome (ALGS) is a rare genetic disorder that can affect the liver, heart and other parts of the body

PolarityTE, Inc. (Nasdaq: PTE), a company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials, today announced the agreement by an accredited investor to exercise certain warrants to purchase up to an aggregate of 10,688,043 shares of common stock having an exercise price of $0.624 issued by the company in December 2020

Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the three months ended September 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth-quarter 2020 financial results on Monday, February 1, 2021 after the financial markets close

Asia Green Biotechnology Corp. (“AGB” or the “Company”) (CSE:ASIA), announced today that, subject to regulatory approval, Mr. Alisdair Leeson, CA, has been appointed as a member of the Board of Directors.

BIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com ): presents unaudited financial results for second quarter of 2021

Less Cancer Founder Bill Couzens today announced that the National Cancer Prevention Workshop will be online on Thursday, February 4 with programming featuring key leaders in cancer prevention, journalism, education and government.

iMFLUX, a subsidiary of P&G, developed a novel fully injection-molded polypropylene nasal swab under the company’s efforts to positively impact COVID-19 testing availability

Global prevalence of diabetic disorders will influence developments in the biosensors market. Rising adaption to sedentary lifestyles and change in eating patterns have led to increased instances of obesity and hormonal disorders, indicating a spike in diabetic conditions.